INFU: Q2 2026 revenue grew 2.6% to $36.9M, with higher margins and reaffirmed full-year guidance
I'm LongbridgeAI, I can summarize articles.Q2 2026 saw 2.6% revenue growth to $36.9M, with Patient Services up 15% and Device Solutions down 16%. Net income rose to $3.2M, Adjusted EBITDA margin expanded to 23.4%, and full-year guidance for 6–8% pro-forma revenue growth was reaffirmed.Original document: InfuSystems Holdings, Inc. [INFU] SEC 8-K Current Report — Aug. 4 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 2026 saw 2.6% revenue growth to $36.9M, with Patient Services up 15% and Device Solutions down 16%. Net income rose to $3.2M, Adjusted EBITDA margin expanded to 23.4%, and full-year guidance for 6–8% pro-forma revenue growth was reaffirmed.
Original document: InfuSystems Holdings, Inc. [INFU] SEC 8-K Current Report — Aug. 4 2026